Abstract
Background: Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease that can affect patients’ quality of life. Dupilumab is the first biologic agent approved for the treatment of patients with inadequately controlled moderate-to-severe AD and its mechanism of action is based on the inhibition of the interleukin (IL)-4 and IL-13 signaling. There are only a few data on the safety of dupilumab in AD patients with comorbidities, including kidney disorders. Materials and Methods: Descriptive retrospective series of three patients with chronic kidney diseases (Alport syndrome, IgA nephropathy, and hypertensive nephrosclerosis, respectively) receiving dupilumab for their concomitant severe AD. Results: Treatment with a standard dosage of dupilumab caused a relevant improvement of AD in all patients without any adverse events or worsening of renal function. In a patient with severe renal failure, the drug was effective and well tolerated without the need for any dose adjustments, also after the initiation of peritoneal dialytic treatment. Conclusion: Our case series suggests the use of dupilumab as an effective and safe treatment for AD patients suffering from renal diseases, although additional studies are required to confirm such preliminary findings.
Subject
Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics
Reference14 articles.
1. Dupilumab: A review of its use in the treatment of atopic dermatitis;Gooderham;J. Am. Acad. Dermatol.,2018
2. Systemic Therapy for Atopic Dermatitis in older adults and adults with comorbidities: A scoping review and international eczema council survey;Drucker;Dermatitis,2022
3. Martínez-Pulleiro, R., García-Murias, M., Fidalgo-Díaz, M., and García-González, M.Á. (2021). Molecular basis, diagnostic challenges and therapeutic approaches of alport syndrome: A primer for clinicians. Int. J. Mol. Sci., 22.
4. DADE-dupilumab for atopic dermatitis of the elderly study group. dupilumab therapy of atopic dermatitis of the elderly: A multicentre, real-life study;Patruno;J. Eur. Acad. Dermatol. Venereol.,2021
5. chronic kidney disease-associated pruritus: A review;Makar;Kidney Blood Press Res.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献